301 related articles for article (PubMed ID: 25706657)
1. Radiation therapy after radical prostatectomy for prostate cancer: evaluation of complications and influence of radiation timing on outcomes in a large, population-based cohort.
Hegarty SE; Hyslop T; Dicker AP; Showalter TN
PLoS One; 2015; 10(2):e0118430. PubMed ID: 25706657
[TBL] [Abstract][Full Text] [Related]
2. Assessing adverse events of postprostatectomy radiation therapy for prostate cancer: evaluation of outcomes in the Regione Emilia-Romagna, Italy.
Showalter TN; Hegarty SE; Rabinowitz C; Maio V; Hyslop T; Dicker AP; Louis DZ
Int J Radiat Oncol Biol Phys; 2015 Mar; 91(4):752-9. PubMed ID: 25752388
[TBL] [Abstract][Full Text] [Related]
3. Optimal timing of early versus delayed adjuvant radiotherapy following radical prostatectomy for locally advanced prostate cancer.
Kowalczyk KJ; Gu X; Nguyen PL; Lipsitz SR; Trinh QD; Lynch JH; Collins SP; Hu JC
Urol Oncol; 2014 Apr; 32(3):303-8. PubMed ID: 24321259
[TBL] [Abstract][Full Text] [Related]
4. Radiotherapy after radical prostatectomy: Effect of timing of postprostatectomy radiation on functional outcomes.
Huelster HL; Laviana AA; Joyce DD; Huang LC; Zhao Z; Koyama T; Hoffman KE; Conwill R; Goodman M; Hamilton AS; Wu XC; Paddock LE; Stroup A; Cooperberg M; Hashibe M; O'Neil BB; Kaplan SH; Greenfield S; Penson DF; Barocas DA
Urol Oncol; 2020 Dec; 38(12):930.e23-930.e32. PubMed ID: 32736934
[TBL] [Abstract][Full Text] [Related]
5. Postoperative radiation therapy for patients at high-risk of recurrence after radical prostatectomy: does timing matter?
Hsu CC; Paciorek AT; Cooperberg MR; Roach M; Hsu IC; Carroll PR
BJU Int; 2015 Nov; 116(5):713-20. PubMed ID: 25600860
[TBL] [Abstract][Full Text] [Related]
6. Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.
Ploussard G; Agamy MA; Alenda O; Allory Y; Mouracade P; Vordos D; Hoznek A; Abbou CC; de la Taille A; Salomon L
BJU Int; 2011 Jun; 107(11):1748-54. PubMed ID: 20883488
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of post-operative radiation in a prostatectomy cohort adjusted for clinical and genomic risk.
Ross AE; Den RB; Yousefi K; Trock BJ; Tosoian J; Davicioni E; Thompson DJ; Choeurng V; Haddad Z; Tran PT; Trabulsi EJ; Gomella LG; Lallas CD; Abdollah F; Feng FY; Klein EA; Dicker AP; Freedland SJ; Karnes RJ; Schaeffer EM
Prostate Cancer Prostatic Dis; 2016 Sep; 19(3):277-82. PubMed ID: 27136742
[TBL] [Abstract][Full Text] [Related]
8. A Phase III trial to investigate the timing of radiotherapy for prostate cancer with high-risk features: background and rationale of the Radiotherapy -- Adjuvant Versus Early Salvage (RAVES) trial.
Pearse M; Fraser-Browne C; Davis ID; Duchesne GM; Fisher R; Frydenberg M; Haworth A; Jose C; Joseph DJ; Lim TS; Matthews J; Millar J; Sidhom M; Spry NA; Tang CI; Turner S; Williams SG; Wiltshire K; Woo HH; Kneebone A
BJU Int; 2014 Mar; 113 Suppl 2():7-12. PubMed ID: 24894850
[TBL] [Abstract][Full Text] [Related]
9. Improved toxicity profile following high-dose postprostatectomy salvage radiation therapy with intensity-modulated radiation therapy.
Goenka A; Magsanoc JM; Pei X; Schechter M; Kollmeier M; Cox B; Scardino PT; Eastham JA; Zelefsky MJ
Eur Urol; 2011 Dec; 60(6):1142-8. PubMed ID: 21855208
[TBL] [Abstract][Full Text] [Related]
10. Risk stratification of patients with extraprostatic extension and negative lymph nodes at radical prostatectomy: identifying optimal candidates for adjuvant therapy.
Eisenberg MS; Karnes RJ; Kaushik D; Rangel L; Bergstralh EJ; Boorjian SA
J Urol; 2013 Nov; 190(5):1735-41. PubMed ID: 23727312
[TBL] [Abstract][Full Text] [Related]
11. Early salvage radiation therapy does not compromise cancer control in patients with pT3N0 prostate cancer after radical prostatectomy: results of a match-controlled multi-institutional analysis.
Briganti A; Wiegel T; Joniau S; Cozzarini C; Bianchi M; Sun M; Tombal B; Haustermans K; Budiharto T; Hinkelbein W; Di Muzio N; Karakiewicz PI; Montorsi F; Van Poppel H
Eur Urol; 2012 Sep; 62(3):472-87. PubMed ID: 22633803
[TBL] [Abstract][Full Text] [Related]
12. Impact of timing on salvage radiation therapy adverse events following radical prostatectomy: A secondary analysis of the RTOG 9601 cohort.
Baumgarten L; Borchert A; Sood A; Dalela D; Arora S; Keeley J; Rogers C; Peabody J; Menon M; Abdollah F
Urol Oncol; 2020 Feb; 38(2):38.e17-38.e22. PubMed ID: 31653564
[TBL] [Abstract][Full Text] [Related]
13. Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features.
Vargas C; Kestin LL; Weed DW; Krauss D; Vicini FA; Martinez AA
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):714-24. PubMed ID: 15708249
[TBL] [Abstract][Full Text] [Related]
14. Health-related quality of life results in pathologic stage C prostate cancer from a Southwest Oncology Group trial comparing radical prostatectomy alone with radical prostatectomy plus radiation therapy.
Moinpour CM; Hayden KA; Unger JM; Thompson IM; Redman MW; Canby-Hagino ED; Higgins BA; Sullivan JW; Lemmon D; Breslin S; Crawford ED; Southwest Oncology Group
J Clin Oncol; 2008 Jan; 26(1):112-20. PubMed ID: 18165645
[TBL] [Abstract][Full Text] [Related]
15. Long-term rates of undetectable PSA with initial observation and delayed salvage radiotherapy after radical prostatectomy.
Loeb S; Roehl KA; Viprakasit DP; Catalona WJ
Eur Urol; 2008 Jul; 54(1):88-94. PubMed ID: 18400368
[TBL] [Abstract][Full Text] [Related]
16. Larger maximum tumor diameter at radical prostatectomy is associated with increased biochemical failure, metastasis, and death from prostate cancer after salvage radiation for prostate cancer.
Johnson SB; Hamstra DA; Jackson WC; Zhou J; Foster B; Foster C; Song Y; Li D; Palapattu GS; Kunju L; Mehra R; Sandler H; Feng FY
Int J Radiat Oncol Biol Phys; 2013 Oct; 87(2):275-81. PubMed ID: 23886418
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant and salvage radiotherapy after prostatectomy: AUA/ASTRO Guideline.
Thompson IM; Valicenti RK; Albertsen P; Davis BJ; Goldenberg SL; Hahn C; Klein E; Michalski J; Roach M; Sartor O; Wolf JS; Faraday MM
J Urol; 2013 Aug; 190(2):441-9. PubMed ID: 23707439
[TBL] [Abstract][Full Text] [Related]
18. Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcome.
Ward JF; Slezak JM; Blute ML; Bergstralh EJ; Zincke H
BJU Int; 2005 Apr; 95(6):751-6. PubMed ID: 15794776
[TBL] [Abstract][Full Text] [Related]
19. Patterns of care and outcomes of radiotherapy for lymph node positivity after radical prostatectomy.
Kaplan JR; Kowalczyk KJ; Borza T; Gu X; Lipsitz SR; Nguyen PL; Friedlander DF; Trinh QD; Hu JC
BJU Int; 2013 Jun; 111(8):1208-14. PubMed ID: 23551838
[TBL] [Abstract][Full Text] [Related]
20. Sexual function with localized prostate cancer: active surveillance vs radical therapy.
van den Bergh RC; Korfage IJ; Roobol MJ; Bangma CH; de Koning HJ; Steyerberg EW; Essink-Bot ML
BJU Int; 2012 Oct; 110(7):1032-9. PubMed ID: 22260273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
